Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT03872427
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-14
First Post:
2019-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-04-16
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-12
First Submit QC Date:
None
Study First Post Date:
2019-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-17
Results First Submit QC Date:
None
Results First Post Date:
2025-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-31
Last Update Post Date:
2025-11-14
Last Update Post Date Type:
ESTIMATED